Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1988 1
2001 1
2003 1
2007 1
2008 1
2011 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Intestinal graft-versus-host disease: mechanisms and management.
Takatsuka H, Iwasaki T, Okamoto T, Kakishita E. Takatsuka H, et al. Drugs. 2003;63(1):1-15. doi: 10.2165/00003495-200363010-00001. Drugs. 2003. PMID: 12487619 Review.
Allogeneic haematopoietic stem cell transplantation remains the treatment of choice for a number of malignancies. However, graft-versus-host disease (GVHD) has long been regarded as a serious complication of this procedure. ...The evidence-based the …
Allogeneic haematopoietic stem cell transplantation remains the treatment of choice for a number of malignancies. However, graft-v …
GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity.
Zeiser R, Warnatz K, Rosshart S, Sagar, Tanriver Y. Zeiser R, et al. Eur J Immunol. 2022 Sep;52(9):1406-1418. doi: 10.1002/eji.202149530. Epub 2022 Apr 13. Eur J Immunol. 2022. PMID: 35339113 Free article. Review.
Impaired immunity in the intestinal tract can lead to immunopathology, which manifests in different diseases such as inflammatory bowel disease or intestinal graft-versus-host disease. A disturbed communication between epithelial c …
Impaired immunity in the intestinal tract can lead to immunopathology, which manifests in different diseases such as inflammatory bow …
Treatment of intestinal graft-versus-host disease using betamethasone enemas.
Wada H, Mori A, Okada M, Takatsuka H, Tamura A, Seto Y, Iwata N, Fujimori Y, Okamoto T, Takemoto Y, Kakishita E. Wada H, et al. Transplantation. 2001 Oct 27;72(8):1451-3. doi: 10.1097/00007890-200110270-00020. Transplantation. 2001. PMID: 11685119
Intestinal graft-versus-host disease (GVHD) can readily easily induce generalized metabolic disturbance that influences morbidity and mortality after allogeneic bone marrow transplantation. Although adding a new drug or increasing the doses of i …
Intestinal graft-versus-host disease (GVHD) can readily easily induce generalized metabolic disturbance t …
Nutritional management of patients with intestinal graft-versus-host disease.
Gauvreau JM, Lenssen P, Cheney CL, Aker SN, Hutchinson ML, Barale KV. Gauvreau JM, et al. J Am Diet Assoc. 1981 Dec;79(6):673-7. J Am Diet Assoc. 1981. PMID: 6796619
Gastrointestinal Graft-Versus-Host Disease (GI GVHD) may occur following bone marrow transplantation for the treatment of acute leukemia or aplastic anemia. The resulting GI damage leads to symptoms including altered intestinal mobility, malabso …
Gastrointestinal Graft-Versus-Host Disease (GI GVHD) may occur following bone marrow transplantation for the tre …
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient.
Merli P, Massa M, Russo A, Rea F, Del Chierico F, Galaverna F, Del Bufalo F, Pane S, Algeri M, Romeo EF, Masucci L, De Angelis P, Putignani L, Locatelli F. Merli P, et al. Bone Marrow Transplant. 2022 Oct;57(10):1600-1603. doi: 10.1038/s41409-022-01752-0. Epub 2022 Jul 14. Bone Marrow Transplant. 2022. PMID: 35835996 No abstract available.
Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography.
Stelljes M, Hermann S, Albring J, Köhler G, Löffler M, Franzius C, Poremba C, Schlösser V, Volkmann S, Opitz C, Bremer C, Kucharzik T, Silling G, Schober O, Berdel WE, Schäfers M, Kienast J. Stelljes M, et al. Blood. 2008 Mar 1;111(5):2909-18. doi: 10.1182/blood-2007-10-119164. Epub 2007 Dec 5. Blood. 2008. PMID: 18057227 Free article.
Gastrointestinal graft-versus-host disease (GVHD) is a common and potentially life-threatening complication after allogeneic hematopoietic stem-cell transplantation (HSCT). ...No increased FDG uptake was detected in 13 patients without histologic evide …
Gastrointestinal graft-versus-host disease (GVHD) is a common and potentially life-threatening complication afte …
Treatment of acute graft-versus-host disease after HLA-partially matched marrow transplantation with a monoclonal antibody (BMA031) against the T cell receptor. First results of a phase-I/II trial.
Beelen DW, Graeven U, Schulz G, Grosse-Wilde H, Doxiadis I, Schaefer UW, Quabeck K, Sayer H, Schmidt CG. Beelen DW, et al. Onkologie. 1988 Feb;11(1):56-8. doi: 10.1159/000216484. Onkologie. 1988. PMID: 3283628
As part of an ongoing phase-I/II trial, 2 patients received a 5-day treatment course with a murine monoclonal antibody (MAB) directed against the human T cell receptor (BMA031) as primary therapy of acute grade III skin and gastro-intestinal graft-versus …
As part of an ongoing phase-I/II trial, 2 patients received a 5-day treatment course with a murine monoclonal antibody (MAB) directed agains …